InspireMD Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $1.65M Beat $1.55M Estimate

Author: Benzinga Newsdesk | August 08, 2023 07:07am
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) by 20 percent. This is a 59.32 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $1.65 million which beat the analyst consensus estimate of $1.55 million by 6.39 percent. This is a 7.71 percent increase over sales of $1.53 million the same period last year.

Posted In: NSPR